IXICO plc (LON:IXI – Get Free Report)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 7.99 and traded as low as GBX 7.56. IXICO shares last traded at GBX 7.56, with a volume of 8,219 shares trading hands.
IXICO Trading Down 2.5%
The stock has a market cap of £16.55 million, a P/E ratio of -3.87, a PEG ratio of -0.38 and a beta of 0.13. The firm’s fifty day moving average price is GBX 8.16 and its two-hundred day moving average price is GBX 7.98. The company has a debt-to-equity ratio of 5.22, a current ratio of 2.83 and a quick ratio of 4.90.
Insider Activity
In related news, insider Mark Warne acquired 50,006 shares of the firm’s stock in a transaction dated Wednesday, July 15th. The shares were purchased at an average price of GBX 8 per share, for a total transaction of £4,000.48. Company insiders own 3.07% of the company’s stock.
About IXICO
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
Further Reading
- Five stocks we like better than IXICO
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
